(Q43407447)

23 November 2017

title

Stavudine entry into cerebrospinal fluid after single and multiple doses in patients infected with human immunodeficiency virus (English)

1 reference

23 November 2017

0 references

1 reference

Kathleen A Brady

1

1 reference

23 November 2017

Ray C Boston

series ordinal

2

1 reference

23 November 2017

Jennifer L Aldrich

series ordinal

3

1 reference

23 November 2017

Rob Roy MacGregor

series ordinal

4

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

23 November 2017

1 reference

23 November 2017

volume

25

1 reference

23 November 2017

issue

1

1 reference

23 November 2017

page(s)

10-17

1 reference

Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.10.55625

Clinical pharmacokinetics of stavudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.10.55625

Protein binding in antiretroviral therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.10.55625

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.10.55625

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.10.55625

Early viral brain invasion in iatrogenic human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.10.55625

Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.10.55625

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.10.55625

Clinical pharmacokinetics of nucleoside antiretroviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.10.55625

Stavudine: a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.10.55625

10.1592/PHCO.25.1.10.55625

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference